Author

Steven M. Finegan

Observed names: Finegan, S.M., S FINEGAN, S. M. FINEGAN, S. M. Finegan, S.M. Finegan, Steve Finegan, Steven Finegan

Institution: Pfizer (United States)

Observed institutions: University of the Sciences, Pfizer (United States), University at Buffalo, State University of New York

OpenAlex ID: A5110070337

Adaptation-Based Resistance to Siderophore-Conjugated Antibacterial Agents by Pseudomonas aeruginosa

2013 · Andrew P. Tomaras, Jared L. Crandon, et al. · Antimicrobial Agents and Chemotherapy · 110

Clinically Relevant Gram-Negative Resistance Mechanisms Have No Effect on the Efficacy of MC-1, a Novel Siderophore-Conjugated Monocarbam

2012 · Craig J. McPherson, Lisa M. Aschenbrenner, et al. · Antimicrobial Agents and Chemotherapy · 91

Preparation, Gram-Negative Antibacterial Activity, and Hydrolytic Stability of Novel Siderophore-Conjugated Monocarbam Diols

2011 · Mark E. Flanagan, Steven J. Brickner, et al. · ACS Medicinal Chemistry Letters · 72

Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models

2005 · D. Girard, S. M. Finegan, et al. · Journal of Antimicrobial Chemotherapy · 67

Discovery of Azetidinyl Ketolides for the Treatment of Susceptible and Multidrug Resistant Community-Acquired Respiratory Tract Infections

2009 · Thomas V. Magee, Sharon L. Ripp, et al. · Journal of Medicinal Chemistry · 54

Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV

2017 · Mark J. Mitton-Fry, Steven J. Brickner, et al. · Bioorganic & Medicinal Chemistry Letters · 34

Cyclic homopentapeptides 1. Analogs of tuberactinomycins and capreomycin with activity against vancomycin-resistant enterococci and Pasteurella

1997 · J.P. Dirlam, A.M. Belton, et al. · Bioorganic & Medicinal Chemistry Letters · 21

Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infections

2012 · Mark J. Mitton-Fry, Joel T. Arcari, et al. · Bioorganic & Medicinal Chemistry Letters · 20

Cyclic homopentapeptides 2. Synthetic modifications of viomycin

1997 · J.P. Lyssikatos, S.-P. Chang, et al. · Bioorganic & Medicinal Chemistry Letters · 12

The discovery and structure–activity relationships leading to CE-156811, a difluorophenyl cyclopropyl fluoroether: A novel potent antibacterial analog derived from hygromycin A

2010 · Phuong T. Le, Steven J. Brickner, et al. · Bioorganic & Medicinal Chemistry Letters · 6

In Vitro Antibacterial Activity of CE-156811, a Novel Analog Derived from Hygromycin A

2008 · Gregory G. Stone, Dennis Girard, et al. · Antimicrobial Agents and Chemotherapy · 4

Corrigendum to “Novel monobactams utilizing a siderophore uptake mechanism for the treatment of Gram-negative infections” [Bioorg. Med. Chem. Lett. 22/18 (2012) 5989–5994]

2015 · Mark J. Mitton-Fry, Joel T. Arcari, et al. · Bioorganic & Medicinal Chemistry Letters · 1

Pharmacokinetics and pharmacodynamics of azithromycin in gerbils with haemophilus influenzae middle ear infection

2005 · O OKUSANYA, A FORREST, et al. · Clinical Pharmacology & Therapeutics · 1

Enhanced Staining of Bacterial Flagella Using Aged Mordant in the Silver Stain

1994 · Steven M. Finegan, Robert A. Smith · Biotechnic & Histochemistry · 1

CCDC 805303: Experimental Crystal Structure Determination

2011 · Magee, T.V., Ripp, S.L., et al. · The Cambridge Structural Database

ChemInform Abstract: Cyclic Homopentapeptides. Part 1. Analogues of Tuberactinomycins and Capreomycin with Activity Against Vancomycin‐Resistant Enterococci and Pasteurella.

1997 · J. P. DIRLAM, A. M. BELTON, et al. · ChemInform

Works count: 16

Citation count: 494

H-index: 9

I10-index: 9